Please assess the completion status of the following clinical trial:

Trial Title: Hypertension Prevention in Pre-Hypertensive Individuals

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* individuals with 30 to 70 years of age with pre-hypertension~Exclusion Criteria:~* low life expectancy~* other indications for the use of diuretics, such as cardiovascular disease~* intolerance to the study drugs~* pregnancy

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): None
- chlortalidone-amiloride (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).